These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 33247590)

  • 21. Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
    Ingersoll MA; Miller DR; Martinez O; Wakefield CB; Hsieh KC; Simha MV; Kao CL; Chen HT; Batra SK; Lin MF
    Cancer Lett; 2016 Dec; 383(1):94-105. PubMed ID: 27687622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL.
    Murtola TJ; Syvälä H; Pennanen P; Bläuer M; Solakivi T; Ylikomi T; Tammela TL
    Eur J Pharmacol; 2011 Dec; 673(1-3):96-100. PubMed ID: 22040920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anticancer potential of metformin on prostate cancer.
    Zaidi S; Gandhi J; Joshi G; Smith NL; Khan SA
    Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):351-361. PubMed ID: 30651580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.
    Mimeault M; Venkatraman G; Johansson SL; Moore E; Henichart JP; Depreux P; Lin MF; Batra SK
    Int J Cancer; 2007 Jan; 120(1):160-9. PubMed ID: 17013895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
    Hoque A; Chen H; Xu XC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin.
    Sáez-Martínez P; Porcel-Pastrana F; Pérez-Gómez JM; Pedraza-Arévalo S; Gómez-Gómez E; Jiménez-Vacas JM; Gahete MD; Luque RM
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
    Joentausta RM; Rannikko A; Murtola TJ
    Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
    Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
    J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
    Issat T; Nowis D; Legat M; Makowski M; Klejman MP; Urbanski J; Skierski J; Koronkiewicz M; Stoklosa T; Brzezinska A; Bil J; Gietka J; Jakóbisiak M; Golab J
    Int J Oncol; 2007 Jun; 30(6):1413-25. PubMed ID: 17487362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
    Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
    Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coffee diterpenes kahweol acetate and cafestol synergistically inhibit the proliferation and migration of prostate cancer cells.
    Iwamoto H; Izumi K; Natsagdorj A; Naito R; Makino T; Kadomoto S; Hiratsuka K; Shigehara K; Kadono Y; Narimoto K; Saito Y; Nakagawa-Goto K; Mizokami A
    Prostate; 2019 Apr; 79(5):468-479. PubMed ID: 30569541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
    Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous treatment with statins and aspirin reduces the risk of prostate cancer detection and tumorigenic properties in prostate cancer cell lines.
    Olivan M; Rigau M; Colás E; Garcia M; Montes M; Sequeiros T; Regis L; Celma A; Planas J; Placer J; Reventós J; de Torres I; Doll A; Morote J
    Biomed Res Int; 2015; 2015():762178. PubMed ID: 25649906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
    Zhang L; Guo F; Gao X; Wu Y
    Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Repurposing of Biguanides in Cancer.
    Zhao H; Swanson KD; Zheng B
    Trends Cancer; 2021 Aug; 7(8):714-730. PubMed ID: 33865798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies.
    Baci D; Bruno A; Cascini C; Gallazzi M; Mortara L; Sessa F; Pelosi G; Albini A; Noonan DM
    J Exp Clin Cancer Res; 2019 Nov; 38(1):464. PubMed ID: 31718684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.
    Gonnissen A; Isebaert S; McKee CM; Muschel RJ; Haustermans K
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.